Beauty Health (SKIN)
(Real Time Quote from BATS)
$1.42 USD
+0.02 (1.43%)
Updated Aug 16, 2024 10:34 AM ET
4-Sell of 5 4
C Value F Growth F Momentum D VGM
The Beauty Health Company (SKIN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$1.95 | $5.00 | $1.00 | 39.29% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for The Beauty Health Company comes to $1.95. The forecasts range from a low of $1.00 to a high of $5.00. The average price target represents an increase of 39.29% from the last closing price of $1.40.
Analyst Price Targets (6 )
Broker Rating
The Beauty Health Company currently has an average brokerage recommendation (ABR) of 3.18 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 3.18 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, two are Strong Buy, representing 18.18% of all recommendations. A month ago, Strong Buy represented 18.18%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 3 | 3 | 3 | 3 | 3 |
ABR | 3.18 | 3.18 | 3.18 | 3.18 | 3.18 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/12/2024 | Cowen & Co. | Oliver Chen | Hold | Hold |
8/12/2024 | Raymond James | Olivia Tong | Strong Sell | Strong Sell |
8/12/2024 | Canaccord Genuity | Susan K Anderson | Hold | Hold |
7/25/2024 | Not Identified | Not Identified | Hold | Hold |
7/11/2024 | Piper Sandler | Korinne N Wolfmeyer | Strong Sell | Strong Sell |
5/10/2024 | William Blair | Margaret Kaczor | Hold | Hold |
3/18/2024 | The Benchmark Company | Bruce D Jackson | Hold | Hold |
3/1/2024 | D.A. Davidson | Linda B Weiser | Strong Buy | Strong Buy |
9/19/2023 | Imperial Capital | Michael Piccolo | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.18 |
ABR (Last week) | 3.18 |
# of Recs in ABR | 11 |
Average Target Price | $1.95 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 149 of 253 |
Current Quarter EPS Est: | -0.10 |